| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 04/26/2006 | CN1762420A Pulse invigorating pill prescription and its preparation method |
| 04/26/2006 | CN1762417A Compound formulation of astragalus root for treating cardiovascular and cerebrovascular diseases, its preparation process and use |
| 04/26/2006 | CN1762400A 'Xuesaitong' formulation and its preparation method |
| 04/26/2006 | CN1762373A 'Xueshuantong' soft capsule and its preparation |
| 04/26/2006 | CN1762372A 'Thrombus-removing' infusion liquid and its preparation method |
| 04/26/2006 | CN1253569C Recombinant platelet collagen receptor glycoprotein VI and its pharmaceutical use |
| 04/26/2006 | CN1253528C Desiccation compositions containing hydrophobic amino acid |
| 04/26/2006 | CN1253452C Thioether subsituted imidazoquinoline compound |
| 04/26/2006 | CN1253204C Biological process for the production of a food product comprising heme-iron and food product obtained with said process |
| 04/26/2006 | CN1253171C Chinese medicine preparation for treating blood viscosity syndrome and its preparing method |
| 04/26/2006 | CN1253150C Xa factor inhibitor on its own and/or combined with platelet anti-aggegating agent |
| 04/25/2006 | US7034182 Compounds to treat Alzheimer's disease |
| 04/25/2006 | US7034160 Anticoagulants, methyl (2R,3R)-2-(3-(amino(imino)methyl)benzyl)-3-((4-(1-oxido-4-pyridinyl) benzoyl)amino)butanoate; therapeutic treatment of cardiovascular disorders |
| 04/25/2006 | US7034159 Pharmaceutical compositions comprising 1-isopropyl-3-[(4-m-toluidino-3-pyridyl)sulphonyl]-urea as active ingredient |
| 04/25/2006 | US7034131 Antibody therapy; immobilization |
| 04/25/2006 | US7034032 1,2,3-triazolo(4,5-d)pyrimidine compounds used to treat cardiovascular disorders |
| 04/25/2006 | US7034031 Modulators of TNF-α signaling |
| 04/25/2006 | US7034027 Method of treating a male or female animal in the treatment of a condition where inhibition of a cGMP-specific PDE is of a therapeutic benefit comprising treating said animal with an effective amount of a pharmaceutical composition with carriers |
| 04/25/2006 | US7034021 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 04/25/2006 | US7034017 Substituted oxazolidinones and their use in the field of blood coagulation |
| 04/25/2006 | US7034006 Use of lipid conjugates in the treatment of disease |
| 04/25/2006 | US7034001 Methods of therapy with thrombin derived peptides |
| 04/25/2006 | US7033994 Medicinal compositions for preventing and treating hemorrhagic diseases associating thrombopathy |
| 04/25/2006 | US7033791 Nucleic acid molecules encoding modified factor VIII proteins, expression products, and methods of making the same |
| 04/25/2006 | US7033788 Saxatilin isolated via gel fitration of venom from vipers, then performing high performance liquid chromatography; for use as anti-platelet aggregation agents and antitumor agents |
| 04/25/2006 | US7033776 Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases |
| 04/25/2006 | US7033615 Methods for regulating levels of zinc, cadmium and calcium in humans and for diagnosing, or screening for the risk of developing, diseases associated with abnormal levels of cadmium, zinc and calcium in body fluids and tissues |
| 04/25/2006 | US7033590 Factor IX/factor IXa activating antibodies and antibody derivatives |
| 04/25/2006 | US7033571 Multiple stimulus reversible hydrogels |
| 04/25/2006 | US7033498 Sorbent cartridge comprising at least sodium zirconium carbonate |
| 04/20/2006 | WO2006041872A2 Thrombin receptor antagonists |
| 04/20/2006 | WO2006041409A1 Medical solution, method for producing and use thereof |
| 04/20/2006 | WO2006041119A1 Hydrazide derivatives |
| 04/20/2006 | WO2006040980A1 Lecithinized superoxide dismutase composition and process for producing the same |
| 04/20/2006 | WO2006040374A1 Synthetic peptides which reduce or eliminate bags formed under the lower rim of the eyes and use thereof in cosmetic or dermopharmaceutical compositions |
| 04/20/2006 | WO2006040318A2 Pi3 kinase gamma inhibitors for the treatment of anaemia |
| 04/20/2006 | US20060084809 Compounds as PDE IV and TNF-inhibitors |
| 04/20/2006 | US20060084661 IL-8 receptor antagonists |
| 04/20/2006 | US20060084648 Ethynyl derivatives as factor xa inhibitors |
| 04/20/2006 | US20060084646 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 04/20/2006 | US20060084614 Anticoagulants; bioavailability, lower toxicity; 1-(glycosyl substituted phenylmethylamino)-4-amidino-benzene derivatives |
| 04/20/2006 | US20060084613 Dipeptide enzyme inhibitor; antiinflammatory agents; autoimmune disease; wound healing agents |
| 04/20/2006 | US20060084137 Coagulation, mechanical agitation; filtration |
| 04/20/2006 | US20060083790 Combination of an ibat inhibitor and a metal salt for the treatment of diarrhoea |
| 04/20/2006 | US20060083784 Amorphous pharmaceutical compositions |
| 04/20/2006 | US20060083740 By modulating the expression of mutant and wild type CD83 gene products produced in a mammal; regulation of T cell and dendritic cell activity; antibodies |
| 04/20/2006 | US20060083733 High-concentration preparation of soluble thrombomodulin |
| 04/20/2006 | US20060083684 Method of radio-labelling biomolecules |
| 04/20/2006 | CA2583670A1 Synthetic peptides reducing or removing bags formed under the lower eye contour and their use in cosmetic or dermopharmaceutical compositions |
| 04/20/2006 | CA2582639A1 Thrombin receptor antagonists |
| 04/20/2006 | CA2580480A1 Pi3 kinase gamma inhibitors for the treatment of anaemia |
| 04/20/2006 | CA2568180A1 Medical solution, method for producing and use thereof |
| 04/19/2006 | EP1647553A1 2-acylaminothiazole derivative or salt thereof |
| 04/19/2006 | EP1646398A2 Formulations comprising factor viia and a factor vii related polypeptide |
| 04/19/2006 | EP1646390A1 A1 adenosine receptor antagonists |
| 04/19/2006 | EP1646373A2 Orodispersible pharmaceutical composition of an antithrombotic compound |
| 04/19/2006 | EP1471924B1 Idraparinux (sanorg 34006) for treatment and secondary prophylaxis of venous thromboemolic events in patients with deep venous thrombosis |
| 04/19/2006 | EP1448564B1 Substituted indolizine-like compounds and methods of use |
| 04/19/2006 | EP1436005A4 Inhibition of neonatal hyperbilirubinemia in breast fed infants |
| 04/19/2006 | EP1294724B1 Pyrrolo¬2,3-d|pyrimidine compounds as immunosuppressive agents |
| 04/19/2006 | EP1294395B1 A COMBINATION PRODUCT COMPRISING MELAGATRAN AND A FACTOR VIIa INHIBITOR |
| 04/19/2006 | EP1212330B1 Androgen receptor modulator compounds and methods |
| 04/19/2006 | EP0885215B1 Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
| 04/19/2006 | EP0811064B1 Mpl ligand analogs |
| 04/19/2006 | CN1761680A Metastin derivative and use thereof |
| 04/19/2006 | CN1761649A Novel heteroaryl-substituted acetone derivatives as inhibitors of phospholipase A2 |
| 04/19/2006 | CN1761479A Use of low molecular weight thrombin inhibitors in cholesterol-lowering therapy |
| 04/19/2006 | CN1760166A New method for picking-up purified resveratrol from giant knotweed |
| 04/19/2006 | CN1759880A Prescription of drop pills for treating thrombus and invigorating pulse-beat, and preparation method |
| 04/19/2006 | CN1759877A Composition of medication for treating anemia, and application |
| 04/19/2006 | CN1759873A Medication for treating hydrocele, dropsy, and preparation method |
| 04/19/2006 | CN1759871A Hemostasis capsule and preparation technique |
| 04/19/2006 | CN1759869A Granules of Chinese traditional medicine, and method of discrimination and testing content |
| 04/19/2006 | CN1759856A Compound preparation of multi-metalloidlothioneins and intrinsic biological active matter of earthworm |
| 04/19/2006 | CN1759849A Recipe of angelica drop pills, and preparation method |
| 04/19/2006 | CN1759842A Clathrate of Breviscapine, medication composition of containng clathrate of Breviscapine, and preparation method |
| 04/19/2006 | CN1759839A Recipe of |
| 04/19/2006 | CN1759837A Slow release tablet of medetofazone |
| 04/19/2006 | CN1759832A Carbazochrome sodium sulfonate for injection, and preparation method |
| 04/19/2006 | CN1252254C Defibrase modified by carbowax |
| 04/19/2006 | CN1252092C Carboxybutyryl chitosan sulfuric ester and preparation method and use thereof |
| 04/19/2006 | CN1252070C Urea substituted imidazoquinolines |
| 04/19/2006 | CN1252040C Novel aryl, alkenyl and alkynl 4-dedimethylamino tetracycline derivatives |
| 04/19/2006 | CN1251741C Medicine for treating anemia and preparing method |
| 04/19/2006 | CN1251723C Pharmaceutical composition for treating idiopathic thrombocytopenic purpura of blood heat type and its preparing process |
| 04/19/2006 | CN1251719C Oral taking drug for treating bleeding from internal hemorrhoid and preparation method |
| 04/19/2006 | CN1251698C Isatis root extract for treating endotoxin blood disease and application |
| 04/19/2006 | CN1251675C Powder injection of ginko and dipyridamole and its preparing method |
| 04/19/2006 | CN1251672C Volume-expansion protection agent and application in treating blood-loss shock |
| 04/18/2006 | US7030242 Selective inhibition of aggrecanase in osteoarthritis treatment |
| 04/18/2006 | US7030238 C-nitroso compounds and use thereof |
| 04/18/2006 | US7030223 Novel protein factors which share homologous sequences and biological activities with megakaryocyte colony-stimulating factor (meg-CSF); genetic engineering |
| 04/18/2006 | US7030218 Extending ligation technique to peptides, polypeptides, other polymers and other molecules via an amide bond; used in the synthesis of optionally polymer-modified, synthetic bioactive proteins, and of pharmaceutical compositions |
| 04/18/2006 | US7030151 Micronized amorphous form for better bioavailability; hypercholesterolemia, hyperlipidemia |
| 04/18/2006 | US7030141 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
| 04/18/2006 | US7030138 Benzamidine derivatives |
| 04/18/2006 | US7030128 Imidazo-pyrimidine derivatives as ligands for GABA receptors |
| 04/18/2006 | US7030110 Cyclic oxyguanidine pyrazinones as protease inhibitors |
| 04/18/2006 | US7029914 DNA encoding SNORF36 receptors |
| 04/18/2006 | US7029906 For reducing carbonyl stress in peritoneal dialysate |